Viewing Study NCT05363293


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-01-01 @ 11:13 AM
Study NCT ID: NCT05363293
Status: COMPLETED
Last Update Posted: 2025-05-14
First Post: 2022-04-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult Subjects
Sponsor: Alzamend Neuro, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-05-04
Start Date Type: ACTUAL
Primary Completion Date: 2023-04-14
Primary Completion Date Type: ACTUAL
Completion Date: 2023-05-15
Completion Date Type: ACTUAL
First Submit Date: 2022-04-27
First Submit QC Date: None
Study First Post Date: 2022-05-05
Study First Post Date Type: ACTUAL
Results First Submit Date: 2024-12-09
Results First Submit QC Date: None
Results First Post Date: 2025-05-14
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-04-25
Last Update Post Date: 2025-05-14
Last Update Post Date Type: ACTUAL